PDGFRB and pancreatic neoplasm: Hashimoto et al. reported high ASAP1 expression or co-overexpression of platelet-derived growth factor receptor-beta (PDGFRβ) and EPB41L5 in pancreatic cancer to be associated with poor prognosis (17).